HKSI Prep

Lesson 1 of 5 · 15 min · free preview

Know your client and the suitability judgement

Every product you recommend rests on two pieces of homework: what you know about the client, and what you know about the product. This lesson goes deeper than the basics. It covers what you must collect under the know-your-client rule, when you can rely on what a client tells you, why a risk score is a starting point rather than an answer, how to think about concentration, what you must explain before the client decides, and how long you must keep the record of your reasoning. The rules are those in force as at 15 Nov 2026: the Code of Conduct (33rd edition, January 2026) and the SFC's FAQs on Compliance with Suitability Obligations (last updated 23 July 2026). The SFC does not approve or endorse any CPT course, including this one: your firm decides whether it counts towards your CPT hours, and only time you actually spend counts.

What you must find out about every client

Para 5.1 of the Code of Conduct requires you to take all reasonable steps to establish the true and full identity of each client, and each client's financial situation, investment experience and investment objectives. Where an account is opened without meeting the client face to face, the method used must still satisfactorily ensure the client's identity.

The SFC's suitability FAQs make the point that this is a positive obligation. It applies whether or not you ever make a recommendation or solicitation (Q2). You collect the information at onboarding and keep it current, not on the day you want to sell something.

The FAQs give examples of what each heading means in practice (Q2). They also list the extra information you need to turn raw facts into a suitability view.

  • Financial situation: annual income, liquid assets or net worth.
  • Investment experience: the types of product the client has invested in, and over what period.
  • Investment objectives: the purpose of investing, such as income generation or capital preservation.
  • For the suitability assessment, also collect investment knowledge, investment horizon, risk tolerance (including tolerance for loss of capital) and, where relevant, the capacity to make regular contributions and to meet extra collateral requirements.

When you can rely on what the client tells you

Once you have made reasonable efforts to obtain information, you may rely on what the client gives you, unless you are aware, or should reasonably be aware, that it is inaccurate or out of date (FAQ Q2). That last phrase matters. If a client told you last month that he has retired, the 'employed full time' box on a form from two years ago is no longer something you can rely on, signed or not.

If a client gives you conflicting or incomplete information, alert the client and seek clarification before you perform the suitability assessment (Q2). A form that ticks both 'capital preservation' and 'high risk tolerance' is not an answer. It is a question you have to ask.

Some clients will only tell you part of the picture. You can still help them, but the FAQs say you must, as a minimum, explain the inherent limitations of any recommendation that result from the missing information, and explain any assumptions you have made (Q2). Write both down.

Each client's information should be properly documented and, where appropriate, updated on a continuous basis. Treat a life event the client mentions in passing, such as a new mortgage, a redundancy, an inheritance or a serious illness, as a know-your-client update, not small talk.

Risk profiling: a tool, not the answer

Most firms use a risk-scoring questionnaire to support a verbal discussion. The FAQs accept this, but the questions, the possible answers and the scoring must be designed to reflect the client's real circumstances and to avoid results skewed towards high risk tolerance (Q3). You must not ask a client to answer the questions in a particular way so that the score matches the risk of a product you are recommending.

Even a well-built score does not settle suitability. The FAQs state plainly that a suitability assessment is not a mechanical risk matching process (Q5B), and that merely matching a product's risk rating with the client's risk tolerance level may not be sufficient (Q5A). You are expected to use professional judgement on whether the product's characteristics and risks, including transaction costs, the effect of gearing and foreign currency risk, are actually suitable for this client and in the client's best interests.

The reverse also holds. For a client with a low or medium risk profile, a proportion of high-risk products in the portfolio may not be unsuitable, as long as the portfolio stays commensurate with the client's risk return profile and you are satisfied the recommendation is likely to meet the client's objectives and other circumstances (Q5A). The question is always the effect on this client's whole position, not whether two labels match.

Know the product as well as the client

Suitability has two sides. The FAQs say you should not recommend investment products you do not understand (Q4). For non-exchange traded products, product due diligence means a thorough understanding of the structure, how the product works, the underlying investments, the level of risk, the standing of the issuer and any guarantor, fees and charges, liquidity, lock-in periods, termination conditions, valuation and custody.

Credit ratings and third-party risk ratings are only one factor. Prospectuses, offering circulars and marketing material should not be treated as self-sufficient or self-explanatory, and you should obtain full explanations from the issuer where appropriate (Q4).

Due diligence can be proportionate to the complexity, opaqueness, risk and liquidity of the product, and it should be repeated at appropriate intervals. For exchange traded products, the FAQs single out derivative warrants, callable bull/bear contracts and L&I products as types that may carry more risk than others. Your firm's product team does the formal work, but you are the one in front of the client. If a term sheet contains a feature you cannot explain, you are not ready to recommend it.

Concentration and the whole portfolio

You should give due consideration to concentration risk, assessed on what you know about the client, such as the portfolio held with your firm and the client's wider financial situation (Q5A). The more a single product, issuer or type of risk dominates a client's wealth, the less room there is for that product to go wrong.

Concentration is also a judgement, not a formula. The FAQs say a concentration assessment should not be a mechanical calculation, and that exceeding a particular level may be acceptable if the outcome is commensurate with the portfolio's overall risk and the client's expertise, risk tolerance and finances (Q5B). Firms may vary their process for wealthy, experienced clients, as long as they can show the overall outcome is reasonably suitable.

In practice, before you recommend, ask how much of the client's liquid wealth this ticket represents and how much the client already holds with the same issuer, sector or product type. A second structured note from the same issuer is a concentration question, not just a product question.

Explain properly, and give the client time

Where available, give the client up-to-date offering documents. For non-exchange traded products, you are expected at least to provide the up-to-date offering documents. But handing over a prospectus, asking the client to read it, or reading it aloud is not enough (Q6A).

Explain why the product suits this client, and the nature and extent of its risks, in simple language the client readily understands. Present a balanced view, drawing attention to the disadvantages and downside risks as well as the good points. Give the client enough time to digest the information and to ask questions. Under no circumstances should you use high-pressure or unfair techniques to push a client into a hasty decision (Q6A).

The depth of explanation can be scaled. A client with little or no experience of a product type needs more help. Explanations may be less intensive for a client with demonstrable expertise in the same product or category (Q6B). Scaling down is a judgement you must be able to justify from the file.

Record the rationale, and keep it

Keep records documenting the rationale for each investment recommendation, and give the client a copy if asked (Q7). Record contemporaneously the information you gave the client, including any material questions the client raised and your answers. A written note or an audio record are both acceptable, depending on how your firm operates.

Footnote 7 of the FAQs (updated 23 July 2026) covers firms that assess suitability on a portfolio basis: they should give the client a copy of the rationale for the investment mandate, and need not give a separate rationale for each later transaction made in line with that mandate.

Para 6.2(i) requires every client agreement to contain the suitability clause. If the firm solicits the sale of or recommends a financial product, it must be reasonably suitable for the client, and no other provision of the agreement, no other document and no statement the client is asked to make derogates from that clause. A signed disclaimer does not cancel your duty.

  • Non-exchange traded products: keep the records for at least 7 years (Q7).
  • Exchange traded products: keep the records for at least 2 years (Q7).
  • If you cannot write a short, honest note of why the product suits this client, do not recommend it.

Enforcement case · 2025-12-11

Bank fined over bond due diligence that missed special features

  • Between January 2015 and December 2020, EFG Bank AG did not take into account one or more special features of 322 bonds when carrying out product due diligence. According to the Statement of Disciplinary Action, two of those bonds were not classified as complex products after the complex product regime took effect in July 2019.
  • After the regime started, the bank also failed on some occasions to give customers sufficient product information, and warning statements for certain complex products, before or at the point of each transaction.
  • It did not keep product due diligence records for 141 bonds, and it did not report its due diligence failures to the SFC immediately when it first suspected them in July 2020.
  • The SFC reprimanded the bank and fined it HK$10.85 million. The bank will apply an enhanced complaint handling procedure to complaints from customers who bought the affected products.

What to do differently: Your suitability judgement is only as good as the product information behind it. If a bond is perpetual, subordinated, extendable or carries loss-absorption features and nobody flags it, the risk rating and the complex product label may both be wrong. Read the term sheet yourself and raise gaps with your product team before you recommend.

Source: SFC press release 25PR205, 11 Dec 2025

Key points

  • Know-your-client under para 5.1 is a positive duty: identity, financial situation, investment experience and objectives, whether or not you recommend anything.
  • Clarify conflicting or incomplete information before assessing suitability, and never steer a client's questionnaire answers.
  • Suitability under para 5.2 is a judgement in all the circumstances, not a mechanical match of risk labels.
  • Know the product: do your own due diligence and do not rely on ratings or marketing material alone.
  • Consider concentration and the effect on the client's whole portfolio.
  • Record the rationale and keep it: at least 7 years for non-exchange traded products and at least 2 years for exchange traded products.

Sources

That was lesson 1 of 5.

This course includes an assessment and a completion record. The SFC does not approve or endorse CPT courses: your firm decides whether it counts toward your CPT, and CPT hours count only for time you actually spend.

See the full course